IL154298A0 - Papap proteins, their preparation and use - Google Patents

Papap proteins, their preparation and use

Info

Publication number
IL154298A0
IL154298A0 IL15429801A IL15429801A IL154298A0 IL 154298 A0 IL154298 A0 IL 154298A0 IL 15429801 A IL15429801 A IL 15429801A IL 15429801 A IL15429801 A IL 15429801A IL 154298 A0 IL154298 A0 IL 154298A0
Authority
IL
Israel
Prior art keywords
papap
proteins
preparation
gene
schizophrenia
Prior art date
Application number
IL15429801A
Other languages
English (en)
Original Assignee
Genset Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genset Sa filed Critical Genset Sa
Publication of IL154298A0 publication Critical patent/IL154298A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Plant Pathology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
IL15429801A 2000-08-07 2001-07-26 Papap proteins, their preparation and use IL154298A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22348200P 2000-08-07 2000-08-07
PCT/IB2001/001891 WO2002012279A2 (en) 2000-08-07 2001-07-26 Schizophrenia related gene and protein

Publications (1)

Publication Number Publication Date
IL154298A0 true IL154298A0 (en) 2003-09-17

Family

ID=22836688

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15429801A IL154298A0 (en) 2000-08-07 2001-07-26 Papap proteins, their preparation and use
IL154298A IL154298A (en) 2000-08-07 2003-02-05 A gene and protein associated with schizophrenia

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL154298A IL154298A (en) 2000-08-07 2003-02-05 A gene and protein associated with schizophrenia

Country Status (15)

Country Link
US (2) US7220581B2 (xx)
EP (1) EP1307560B1 (xx)
JP (1) JP2004516015A (xx)
KR (1) KR100781481B1 (xx)
CN (1) CN1468306A (xx)
AT (1) ATE340856T1 (xx)
AU (2) AU9408801A (xx)
BR (1) BR0113099A (xx)
CA (1) CA2418779A1 (xx)
DE (1) DE60123434D1 (xx)
EA (1) EA005921B1 (xx)
IL (2) IL154298A0 (xx)
MX (1) MXPA03001150A (xx)
UA (1) UA79582C2 (xx)
WO (1) WO2002012279A2 (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7442519B2 (en) 2002-06-25 2008-10-28 Serono Genetics Institute, S.A. KCNQ2-15 potassium channel
WO2004001068A2 (en) * 2002-06-25 2003-12-31 Serono Genetics Institute S.A. Use of pp2a phosphatase modulators in the treatment of mental disorders
US20040038385A1 (en) * 2002-08-26 2004-02-26 Langlois Richard G. System for autonomous monitoring of bioagents
CN100348722C (zh) * 2005-06-16 2007-11-14 吉林大学 精神分裂症关联基因
KR100642345B1 (ko) * 2005-11-02 2006-11-14 주식회사 대한콘설탄트 연약지반 침하방지를 위한 충격흡수형 철로
US20080075789A1 (en) * 2006-02-28 2008-03-27 The Regents Of The University Of California Genes differentially expressed in bipolar disorder and/or schizophrenia
US20140179613A1 (en) 2010-07-09 2014-06-26 The Regents Of The University Of Colorado, A Body Corporate COMPOSITIONS AND METHODS FOR CaMKII INHIBITORS AND USES THEREOF
US8685926B2 (en) 2007-09-26 2014-04-01 The Regents Of The University Of Colorado, A Body Corporate Compositions and method for CaMKII inhibitors and uses thereof
WO2009042906A1 (en) * 2007-09-26 2009-04-02 Regents Of The University Of Colorado Compositions and methods for camkii inhibitors and uses thereof
US8892184B2 (en) 2010-10-18 2014-11-18 Siemens Medical Solutions Usa, Inc. Systems and methods for reducing interference in a dual modality imaging system
CA2885216A1 (en) 2012-09-17 2014-03-20 The Research Institute At Nationwide Children's Hospital Compositions and methods for treating amyotrophic lateral sclerosis
EP3065784A4 (en) * 2013-11-05 2017-05-10 The Research Institute at Nationwide Children's Hospital COMPOSITIONS AND METHODS FOR INHIBITING NF- kB AND SOD-1 TO TREAT AMYOTROPHIC LATERAL SCLEROSIS

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6222027B1 (en) * 1999-05-17 2001-04-24 Incyte Genomics, Inc. Molecules expressed in hippocampus
JP2004506442A (ja) 2000-08-25 2004-03-04 メルク　パテント　ゲゼルシャフト　ミット　ベシュレンクテル　ハフトング ＣａＭ−キナーゼＩＩ阻害剤の同定

Also Published As

Publication number Publication date
US20080199883A1 (en) 2008-08-21
US20030148389A1 (en) 2003-08-07
DE60123434D1 (de) 2006-11-09
EP1307560B1 (en) 2006-09-27
CA2418779A1 (en) 2002-02-14
KR20030042449A (ko) 2003-05-28
JP2004516015A (ja) 2004-06-03
EP1307560A2 (en) 2003-05-07
UA79582C2 (en) 2007-07-10
KR100781481B1 (ko) 2007-12-03
US7220581B2 (en) 2007-05-22
AU9408801A (en) 2002-02-18
BR0113099A (pt) 2004-07-06
WO2002012279A3 (en) 2002-12-27
MXPA03001150A (es) 2005-04-11
CN1468306A (zh) 2004-01-14
ATE340856T1 (de) 2006-10-15
US7449543B2 (en) 2008-11-11
EA200300246A1 (ru) 2003-08-28
IL154298A (en) 2007-12-03
AU2001294088B2 (en) 2006-09-07
WO2002012279A2 (en) 2002-02-14
EA005921B1 (ru) 2005-08-25

Similar Documents

Publication Publication Date Title
MXPA02011656A (es) Moleculas de acido nucleico nrg-2, polipeptidos, y metodos de diagnostico y terapeuticos.
MXPA02012743A (es) Moleculas tipo il-17 y usos de las mismas.
PT1015585E (pt) Homologos de ligandos de tie
HK1076113A1 (en) Specific binding agents of human angiopoietin-2
DE69840966D1 (de) Homolog NL6 des Tie Rezeptor Tyrosinekinase Liganden
WO2000073469A3 (en) Protein kinases
HK1041009A1 (en) Characterization of the soc/crac calcium channel protein family soc/crac
HK1120556A1 (en) Neurotrophic factors
SI1095140T1 (sl) Nevrotrofični dejavniki
IL154298A0 (en) Papap proteins, their preparation and use
WO2001055178A3 (en) Liv-1 related protein, polynucleotides encoding the same and use thereof for treatment of cancer
WO2001068705A3 (en) Il-17 receptor like molecules and uses thereof
AU8727201A (en) Genes involved in intestinal inflammatory diseases and use thereof
MXPA03006218A (es) Receptor de citosina tipo 2 y acidos nucleicos que codifican para lo mismo.
MXPA03000979A (es) Moleculas tipo receptor de complemento c3b/c4b y usos de las mismas.
PL374550A1 (en) Il-17 like molecules and uses thereof
WO2001059120A3 (en) Il-17 like molecules and uses thereof
WO2001074903A3 (en) Cd20/ige-receptor like molecules and uses thereof
WO2004007536A3 (en) Interactions of the epstein-barr virus protein ebna1, and uses thereof
ATE528392T1 (de) Neues protein und dessen dns
EE200100234A (et) PRV-1-geen ja selle kasutamine
WO2002088345A3 (en) Murine dnasex, medicament containing the same and non-human mammal comprising modified dnasex gene
MXPA03000980A (es) Moleculas tipo receptor de complemento c3b/c4b y usos de las mismas.
WO2002017947A3 (de) Verwendung von t-proteinen zur differentiellen charakterisierung und therapie von verletzungen und tumoren des nervensystems
WO2001051642A3 (en) Dna modification proteins

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed